Company Description
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States.
Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature.
The company refers to its technology as Bio-RFID.
The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors.
Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels.
The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018.
Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
| Country | United States |
| IPO Date | Apr 18, 2006 |
| Industry | Hardware, Equipment & Parts |
| Sector | Technology |
| Employees | 15 |
| CEO | Ronald P. Erickson J.D. |
Contact Details
Address: 500 Union Street Seattle, Washington United States | |
| Website | https://www.knowlabs.co |
Stock Details
| Ticker Symbol | KNW |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001074828 |
| CUSIP Number | n/a |
| ISIN Number | US4992381032 |
| Employer ID | 90-0273142 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Ronald P. Erickson J.D. | Founder, Chief Executive Officer, Treasurer & Chairman |
| Dr. John Cronin | Interim Chief Technology Officer & Independent Director |
| Peter Joseph Conley | Chief Financial Officer & Senior Vice President of Intellectual Property |
| Dr. Dominic Klyve Ph.D. | Chief Science Officer |
| Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board |
| Jordyn Hujar | Chief of Staff |
| Leonardo Trautwein | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 11, 2024 | 8-K | Current Report |
| Dec 10, 2024 | 10-K/A | [Amend] Annual Report |
| Nov 14, 2024 | 10-K | Annual Report |
| Oct 31, 2024 | 4/A | [Amend] Filing |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 28, 2024 | 8-K | Current Report |
| Oct 09, 2024 | 8-K/A | [Amend] Current Report |
| Oct 07, 2024 | DEF 14A | Filing |
| Oct 02, 2024 | 8-K | Current Report |
| Sep 27, 2024 | 8-K | Current Report |